HIV-positive individuals are more likely to be diagnosed with major depressive disorder than
HIV-negative individuals. Depression can precede diagnosis and be associated with risk …

The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs
in the multidrug regimens used to treat HIV infection, in accordance with its well …

Background An efavirenz-based regimen (with a 600-mg dose of efavirenz, known as
EFV600) was the World Health Organization preferred first-line treatment for human …

Background Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …

Background Antiretroviral regimens containing tenofovir disoproxil fumarate have been
associated with renal toxicity and reduced bone mineral density. Tenofovir alafenamide is a …

Objective: To determine the prevalence of cognitive complaints and HIV-associated
neurocognitive disorders (HANDs) in a cohort of aviremic HIV-positive patients. To evaluate …

The advent of highly active antiretroviral therapy has prolonged the life expectancy of HIV
patients and decreased the number of adults who progress to AIDS and HIV-associated …

Background: Despite the availability of potent antiretroviral regimens (combination
antiretroviral therapy [cART]), HIV-associated neurocognitive disorders (HAND) are …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: The relationship between efavirenz use and suicidality is not well …

Objective: Prior studies have shown improved neurocognition with initiation of antiretroviral
treatment (ART) in HIV. We hypothesized that stopping ART would be associated with …